HK1176403A1 - 聯合療法和用於評估對治療的抗性的方法 - Google Patents

聯合療法和用於評估對治療的抗性的方法

Info

Publication number
HK1176403A1
HK1176403A1 HK13103752.7A HK13103752A HK1176403A1 HK 1176403 A1 HK1176403 A1 HK 1176403A1 HK 13103752 A HK13103752 A HK 13103752A HK 1176403 A1 HK1176403 A1 HK 1176403A1
Authority
HK
Hong Kong
Prior art keywords
treatment
combination therapy
assessing resistance
assessing
resistance
Prior art date
Application number
HK13103752.7A
Other languages
English (en)
Inventor
John Frederick Boylan
Wei He
Original Assignee
霍夫曼-拉羅奇有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 霍夫曼-拉羅奇有限公司 filed Critical 霍夫曼-拉羅奇有限公司
Publication of HK1176403A1 publication Critical patent/HK1176403A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5412—IL-6
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5421—IL-8
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK13103752.7A 2010-05-19 2013-03-26 聯合療法和用於評估對治療的抗性的方法 HK1176403A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34624710P 2010-05-19 2010-05-19
PCT/EP2011/057909 WO2011144583A1 (en) 2010-05-19 2011-05-17 Combination therapy and method for assessing resistance to treatment

Publications (1)

Publication Number Publication Date
HK1176403A1 true HK1176403A1 (zh) 2013-07-26

Family

ID=44063206

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13103752.7A HK1176403A1 (zh) 2010-05-19 2013-03-26 聯合療法和用於評估對治療的抗性的方法

Country Status (12)

Country Link
US (1) US8309299B2 (zh)
EP (1) EP2572198B1 (zh)
JP (1) JP5680744B2 (zh)
KR (2) KR101718260B1 (zh)
CN (1) CN102893155B (zh)
BR (1) BR112012027970A2 (zh)
CA (1) CA2798181A1 (zh)
ES (1) ES2488628T3 (zh)
HK (1) HK1176403A1 (zh)
MX (1) MX2012013305A (zh)
RU (1) RU2587053C2 (zh)
WO (1) WO2011144583A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015012031A (es) * 2013-03-15 2016-03-08 Nanobiosym Inc Sistemas y métodos para el análisis con dispositivo móvil de ácidos nucleicos y proteínas.
US10933417B2 (en) 2013-03-15 2021-03-02 Nanobiosym, Inc. Systems and methods for mobile device analysis of nucleic acids and proteins
JP6250351B2 (ja) * 2013-09-30 2017-12-20 シスメックス株式会社 好酸球性気道炎症に関する情報の取得方法およびそのような情報を取得するためのマーカー
CN106093217B (zh) * 2015-05-29 2019-02-22 中国人民解放军第三0二医院 一种评价中西药注射剂序贯联用间隔时间的方法
WO2020163222A1 (en) * 2019-02-04 2020-08-13 Promab Biotechnologies, Inc. Nucleic acid sequence encoding chimeric antigen receptor and a short hairpin rna sequence for il-6 or a checkpoint inhibitor
US20230021431A1 (en) * 2020-05-28 2023-01-26 University Of Massachusetts OLIGONUCLEOTIDES FOR SARS-CoV-2 MODULATION

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04325095A (ja) * 1991-04-26 1992-11-13 Tosoh Corp 抗ヒトｉｌ−６モノクロ−ナル抗体及び該抗体を使用するｉｌ−６の測定方法
JPH05215749A (ja) * 1992-02-07 1993-08-24 Toray Ind Inc ヒトインタ−ロイキン−８の免疫学的測定法
CA2281794A1 (en) * 1997-02-21 1998-08-27 Genentech, Inc. Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies
DE60009533T2 (de) 1999-10-13 2005-01-27 Incyte Corp., Palo Alto Multiple analyse von zytokinen
US7349913B2 (en) * 2003-08-21 2008-03-25 Microsoft Corporation Storage platform for organizing, searching, and sharing data
SI1711470T1 (sl) * 2003-09-09 2009-08-31 Hoffmann La Roche Derivati malonamida, ki blokirajo aktivnost gama-sekretaze
AU2005216095B2 (en) * 2004-02-20 2009-09-17 The Regents Of The University Of California Salivary mRNA profiling, biomarkers, and related methods and kits of parts
JP4839674B2 (ja) * 2004-05-14 2011-12-21 東レ株式会社 標的物質を迅速簡便に検出する方法およびそのための酵素免疫学的キット
RU2440342C2 (ru) * 2006-03-27 2012-01-20 Ф.Хоффманн-Ля Рош Аг МАЛОНАМИДНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ γ-СЕКРЕТАЗЫ
BRPI0717587A2 (pt) * 2006-09-20 2013-10-29 Hoffmann La Roche Derivados de 4-oxo-2,3,4,5-tetra-hidro-benzo[b][1,4]diazepina
MX2009007864A (es) * 2007-02-02 2009-07-31 Hoffmann La Roche Derivados de 6-oxo-6,7-dihidro-5h-dibenzo[b,d]azepin-7-ilo.
WO2008131039A2 (en) * 2007-04-16 2008-10-30 Board Of Regents, The University Of Texas System Cardibioindex/cardibioscore and utility of salivary proteome in cardiovascular diagnostics
MA33076B1 (fr) * 2008-01-11 2012-03-01 Hoffmann La Roche Utilisation d'un inhibiteur de la gamma-secretase pour le traitement du cancer
CN101608222A (zh) * 2008-06-20 2009-12-23 上海主健生物工程有限公司 糖尿病遗传检测试剂盒

Also Published As

Publication number Publication date
RU2587053C2 (ru) 2016-06-10
WO2011144583A1 (en) 2011-11-24
ES2488628T3 (es) 2014-08-28
BR112012027970A2 (pt) 2019-09-24
RU2012151434A (ru) 2014-06-27
EP2572198A1 (en) 2013-03-27
KR101718260B1 (ko) 2017-03-20
JP2013527454A (ja) 2013-06-27
CN102893155A (zh) 2013-01-23
CN102893155B (zh) 2016-01-20
KR20150065931A (ko) 2015-06-15
KR101539138B1 (ko) 2015-07-23
EP2572198B1 (en) 2014-06-25
CA2798181A1 (en) 2011-11-24
MX2012013305A (es) 2013-02-01
US8309299B2 (en) 2012-11-13
US20110287025A1 (en) 2011-11-24
KR20130009884A (ko) 2013-01-23
JP5680744B2 (ja) 2015-03-04

Similar Documents

Publication Publication Date Title
IL248530A0 (en) Biomarkers and treatment methods
HK1221184A1 (zh) 吸入設備和方法
ZA201303605B (en) Compounds and methods for treating pain
DK2608777T3 (en) Compositions and Methods for Cardiac Therapy
EP2788075A4 (en) DEVICE AND METHOD FOR REDUCING THE TRANSTHORACOID IMPEDANCE OF A PATIENT
GB2498121B (en) Treatment device and method of use
EP2611496A4 (en) Methods of Treatment
SG10201501123TA (en) Water treatment device and method
ZA201209484B (en) Skin antiaging treatment
EP2552302A4 (en) APPARATUS AND METHOD FOR HUMAN ALGOMETRY
AP2013007178A0 (en) BCMA-based stratification and therapy for multiplemyeloma patients
EP2621420A4 (en) CORNEAL TREATMENT SYSTEM AND METHOD
EP2736474A4 (en) DEVICE AND METHOD FOR NEUROMUSCULAR THERAPY
EP2627331A4 (en) METHODS OF TREATING HYPERURICEMIA AND RELATED DISEASES
EP2731509A4 (en) APPARATUS AND METHOD FOR REPOSITIONING A BODY PART
EP2874647A4 (en) METHOD FOR DIAGNOSIS AND TREATMENT
EP2544655A4 (en) COMPOSITIONS AND METHODS FOR TREATING SKIN
GB201004172D0 (en) Skin treating device
HK1195484A1 (zh) 治療裝置以及治療方法
EP2551358A4 (en) HEAT TREATMENT PROCESS
IL220594A0 (en) Treatment method
ZA201303949B (en) Compounds and methods for skin repair
GB0918392D0 (en) Diagnostic and therapeutic methods
EP2478828A4 (en) ENDOSCOPIC TREATMENT DEVICE AND ENDOSCOPIC TREATMENT METHOD
IL256026A (en) Treatment methods